Projected to grow from US$298.73 billion in 2024 to US$451.87 billion by 2033 at 4.8% CAGR, the CRM diseases market thrives on multi-disease axes. Dive into segmentation by treatment type, regional surges, and challenges in comorbid profiles for type 2 diabetes and hypertension. https://finance.yahoo.com/news/cardiovascular-renal-metabolic-crm-diseases-143500544.html